Sign in
Taking people in United StatesNo phase

Low FODMAP diet with PEG 3350 for constipation-type irritable bowel syndrome

Tests a low FODMAP diet plus PEG 3350 in adults with constipation-type irritable bowel syndrome.

Key facts

Who runs it
University of Michigan
Where
Ann Arbor, United StatesSee the site
Trial code
Registry title
Low FODMAP Plus PEG 3350 for the Treatment of Patients with Irritable Bowel Syndrome-Constipation
Status
Recruiting
People taking part
78 people, planned
Started
8 Nov 2018
Planned end
Jan 2026
Type of study
Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
Treatments tested
  • Low FODMAP diet/PEG 3350
  • sham diet/PEG 3350
Record updated
4 March 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with irritable bowel syndrome with constipation (IBS-C). It tests PEG 3350 plus a low FODMAP diet against PEG 3350 plus a sham diet.

Age
18 years and older
Sex
All sexes
Disease stage
IBS-C by the Rome IV criteria. Belly pain at least 1 day/week in the last 3 months, linked to bowel movements or changes in stool. More than 25% hard stools and less than 25% loose stools.
Earlier treatment
Cannot have had the low FODMAP diet before under a dietician's guidance.

Main reasons for not taking part

  • Any other IBS type than IBS-C, or more than 3 spontaneous bowel movements in the last 7 days of the run-in period
  • Pregnancy
  • Inflammatory bowel disease, severe kidney or liver disease, or other illness affecting the gut
  • Past belly surgery, except appendix, gallbladder, or gynecologic/urologic surgery more than six months before joining
  • Taking probiotics, antibiotics, IBS medicines or narcotics, starting an antidepressant less than 3 months ago, or being on another diet therapy

The registry criteria, word for word

Show all 18 criteriaShow less

Who can take part

  • Subjects aged 18 and older meeting the Rome IV criteria for IBS-C*:
  • Recurrent abdominal pain, on average, at least 1 day/week in the last 3 months, associated with two or more of the following:
  • related to defecation
  • associated with a change in the frequency of stool (reduction of stools)
  • associated with a change in the form of stool (hard or lumpy stools) AND >25% hard stools and <25% loose stools * Criteria fulfilled for the last 3 months

Who cannot take part

  • Previous abdominal surgery other than appendectomy, cholecystectomy, and gynecologic/urologic surgery if performed more than six months prior to enrollment
  • Previous treatment with the low FODMAP diet under a dietician guidance
  • Concurrent medications not permitted including probiotics, antibiotics, prescription or over-the-counter medication for IBS, and narcotics
  • Active participation in another form of dietary therapy
  • Inflammatory bowel disease
  • Extra-intestinal disease known to affect the gastrointestinal system (i.e., scleroderma, unstable thyroid disease, etc.)
  • Severe renal or hepatic disease
  • any other IBS subtype other than IBS-C
  • >3 spontaneous bowel movements during the last 7 days of run-in
  • Have cognitive dysfunction or unable to understand or provide written informed consent
  • Pregnancy (evaluated by self-report)
  • Comorbid medical problems that may affect gastrointestinal transit or motility:
  • New antidepressant use (less than 3 months on stable dose)

Where in United States

  • University of MichiganAnn Arbor, United StatesContact: Stacy Menees, MDTaking people

About the trial

What the trial wants to find out

Consecutive patients with Irritable Bowel Syndrome with Constipation (IBS-C) will be recruited from the outpatient clinics of the University of Michigan Health System. Eligible patients will be asked to participate in a study that will test the efficacy the PEG 3350 + a diet low in fermentable oligo, di, monosaccharides, and polyols (FODMAP) vs. PEG 3350 plus sham diet. Blinding dietary advice trials is challenging and therefore the sham diet was based on the criteria set forth by Staudacher et al. which emphasizes that the diet must give the impression that is the true intervention diet with similar restrictions, modifications, and time intensity without impacting the intake of essential nutrients, fiber, and FODMAPs. An example of the sham diet's carbohydrates includes: apples, bananas, and pears, and wheat. Oranges, raspberries, strawberries and rice would not be allowed. Additionally, the physicians analyzing the data will be blinded as to which group the patients were randomized.

The 2 groups in the trial

  • Low FODMAP diet plus PEG 3350Treatment being tested

    Subjects will follow a low FODMAP diet and will take PEG 3350 (Miralax).

    Treatment: Low FODMAP diet/PEG 3350

  • Sham diet plus PEG 3350Sham treatment, for comparison

    Subjects will follow a sham diet and will take PEG 3350 (Miralax).

    Treatment: sham diet/PEG 3350

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Low FODMAP Plus PEG 3350 for the Treatment of Patients with Irritable Bowel Syndrome-Constipation
Plain-language title
Low FODMAP diet with PEG 3350 for constipation-type irritable bowel syndromeGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Record updated
4 March 2025